Tenable Holdings Valuation
Is TENB * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TENB * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TENB * (MX$794.67) is trading below our estimate of fair value (MX$1105.52)
Significantly Below Fair Value: TENB * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TENB *?
Key metric: As TENB * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is TENB *'s PS Ratio? | |
---|---|
PS Ratio | 5.8x |
Sales | US$877.60m |
Market Cap | US$5.10b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5.7x |
Enterprise Value/EBITDA | 329.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does TENB *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 15.3x | ||
500408 Tata Elxsi | 11.4x | 13.0% | ₹410.1b |
QLYS Qualys | 9.5x | 7.2% | US$5.6b |
VRNS Varonis Systems | 10.3x | 11.6% | US$5.6b |
688692 Wuhan Dameng Database | 30.1x | 17.4% | CN¥31.3b |
TENB * Tenable Holdings | 5.8x | 9.3% | Mex$5.1b |
Price-To-Sales vs Peers: TENB * is good value based on its Price-To-Sales Ratio (5.8x) compared to the peer average (15.7x).
Price to Sales Ratio vs Industry
How does TENB *'s PS Ratio compare vs other companies in the Global Software Industry?
243 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
243 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: TENB * is expensive based on its Price-To-Sales Ratio (5.8x) compared to the Global Software industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is TENB *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 5.8x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate TENB *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$973.84 0% | 9.6% | Mex$1,106.44 | Mex$804.68 | n/a | 19 |
Nov ’25 | Mex$794.67 | Mex$968.94 +21.9% | 9.6% | Mex$1,100.88 | Mex$800.64 | n/a | 19 |
Oct ’25 | n/a | Mex$1,006.90 0% | 10.1% | Mex$1,119.55 | Mex$785.65 | n/a | 18 |
Sep ’25 | n/a | Mex$993.95 0% | 9.9% | Mex$1,106.59 | Mex$776.56 | n/a | 19 |
Aug ’25 | n/a | Mex$960.57 0% | 9.8% | Mex$1,070.01 | Mex$750.88 | n/a | 19 |
Jul ’25 | n/a | Mex$1,054.08 0% | 9.5% | Mex$1,192.95 | Mex$789.18 | n/a | 19 |
Jun ’25 | n/a | Mex$979.99 0% | 9.5% | Mex$1,104.62 | Mex$730.75 | n/a | 18 |
May ’25 | n/a | Mex$998.22 0% | 9.2% | Mex$1,113.24 | Mex$736.45 | n/a | 19 |
Apr ’25 | n/a | Mex$999.29 0% | 8.7% | Mex$1,111.38 | Mex$735.22 | n/a | 18 |
Mar ’25 | n/a | Mex$999.29 0% | 8.7% | Mex$1,111.38 | Mex$735.22 | n/a | 18 |
Feb ’25 | n/a | Mex$909.34 0% | 11.3% | Mex$1,118.57 | Mex$636.72 | n/a | 19 |
Jan ’25 | n/a | Mex$862.43 0% | 10.6% | Mex$978.57 | Mex$635.21 | n/a | 17 |
Dec ’24 | Mex$721.03 | Mex$858.91 +19.1% | 11.0% | Mex$989.05 | Mex$642.02 | n/a | 16 |
Nov ’24 | Mex$750.00 | Mex$977.30 +30.3% | 7.4% | Mex$1,122.17 | Mex$837.18 | Mex$794.67 | 15 |
Oct ’24 | Mex$790.31 | Mex$947.29 +19.9% | 7.1% | Mex$1,078.94 | Mex$822.05 | n/a | 16 |
Sep ’24 | n/a | Mex$921.57 0% | 7.0% | Mex$1,009.02 | Mex$807.22 | n/a | 15 |
Aug ’24 | n/a | Mex$910.60 0% | 6.3% | Mex$1,010.44 | Mex$808.35 | n/a | 14 |
Jul ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
Jun ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
May ’24 | n/a | Mex$865.90 0% | 8.0% | Mex$995.36 | Mex$760.10 | n/a | 13 |
Apr ’24 | n/a | Mex$956.57 0% | 8.6% | Mex$1,171.46 | Mex$847.05 | n/a | 13 |
Mar ’24 | n/a | Mex$1,000.97 0% | 8.5% | Mex$1,230.92 | Mex$890.05 | n/a | 14 |
Feb ’24 | Mex$755.62 | Mex$914.58 +21.0% | 9.7% | Mex$1,129.77 | Mex$790.84 | n/a | 14 |
Jan ’24 | Mex$706.03 | Mex$959.32 +35.9% | 12.3% | Mex$1,190.30 | Mex$734.02 | n/a | 14 |
Dec ’23 | n/a | Mex$959.32 0% | 12.3% | Mex$1,190.30 | Mex$734.02 | Mex$721.03 | 14 |
Nov ’23 | Mex$793.67 | Mex$959.32 +20.9% | 12.3% | Mex$1,190.30 | Mex$734.02 | Mex$750.00 | 14 |
Analyst Forecast: Target price is less than 20% higher than the current share price.